ELIGIBILITY
Eligible teams must include an engineer or scientist AND a practicing clinician, preferably with an appointment at Columbia University Medical Center. One of these individuals must be a Columbia faculty member and the technology must be based on Columbia Intellectual Property. If you need an engineering or clinical collaborator, we may be able to facilitate introductions.
All members of the team should be committed to commercialization objectives and be open to receiving mentorship, coaching, and oversight of their projects.
All technologies that may have a direct impact on human health will be considered (e.g. therapeutic drugs and devices, medical imaging, monitoring devices, biosensors, biomaterials, and platform technologies, etc.). However, the most relevant are those where time to market can be achieved in less than 7 years.
Projects that propose to undertake discovery research will not be selected. Successful proposals must be translational in nature, i.e. they must focus on efforts to translate research results into practical clinical application.
If you received an award from the Columbia Biomedical Engineering Technology Accelerator in previous years (formerly the Columbia-Coulter Translational Research Partnership), you may be eligible to apply for additional funding to support your project. Such additional funding is contingent on successful achievement of your previous milestones and demonstration of compelling market feedback requiring additional technical development, among other factors. To explore further, please contact us at biomedx@columbia.edu.
